Using macrophage patterns to predict which DCIS will become invasive breast cancer

Studying macrophage polarization in search for predictive and prognostic markers of breast cancer

['FUNDING_R01'] · STANFORD UNIVERSITY · NIH-11300992

This work looks at immune cells called macrophages in breast tissue to help identify which women with DCIS are more likely to develop invasive breast cancer.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorSTANFORD UNIVERSITY (nih funded)
Locations1 site (STANFORD, UNITED STATES)
Trial IDNIH-11300992 on ClinicalTrials.gov

What this research studies

Researchers will examine breast tissue samples from women with ductal carcinoma in situ (DCIS) using laboratory methods that work on standard archived (FFPE) tissue. They will identify different macrophage subtypes with newly developed, tissue-compatible markers and map where those cells sit in the tumor microenvironment. Those macrophage patterns will be linked to known clinical outcomes to see which patterns are associated with progression to invasive cancer. The aim is to find immune-related tissue markers that could help guide less aggressive care for low-risk patients.

Who could benefit from this research

Good fit: Women diagnosed with ductal carcinoma in situ (DCIS) who have archived tumor tissue and documented follow-up would be the most relevant candidates.

Not a fit: People without DCIS or those already treated for invasive breast cancer are unlikely to benefit directly from this project.

Why it matters

Potential benefit: If successful, this could help doctors distinguish low-risk DCIS that may not need surgery or radiation from high-risk cases that do.

How similar studies have performed: Early work by the team identified macrophage subtypes and markers and supports the approach, but it is still novel and not yet proven to guide clinical care.

Where this research is happening

STANFORD, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Breast Cancer, Breast Diseases, Breast Disorder, Cancer Biology, Cancer Treatment

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.